Proteins key to understanding DR

Article

Diabetes-induced changes to 37 separate proteins of the vitreous may be the key to understanding the mechanisms of diabetic retinopathy (DR), according to a study to be published in the June issue of the Journal of Proteome Research.

Diabetes-induced changes to 37 separate proteins of the vitreous may be the key to understanding the mechanisms of diabetic retinopathy (DR), according to a study to be published in the June issue of the Journal of Proteome Research.

Edward P. Feener, PhD of Harvard Medical School, US and colleagues performed a proteomic analysis and compared vitreous samples from 17 subjects, comprising those without diabetes (NDM), those with diabetes but without DR (noDR), and those with DR.

The team found that, of the 252 proteins identified in the vitreous, 56 were found to be in statistically significantly different levels in noDR and DR subjects compared with NDM subjects. This included 32 proteins that were increased and 10 proteins that were decreased in DR subjects compared with NDM subjects. Of the 30 proteins associated with the kallikrein-kinin, coagulation, and complement systems within the vitreous, five were increased in DR subjects compared with NDM subjects. Factor XII was present only in the vitreous of DR subjects.

This new understanding of the biochemical changes found in the eyes of DR patients could, the team believes, further understanding of DR mechanisms of action, thereby leading to new treatment options.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
Related Content
© 2025 MJH Life Sciences

All rights reserved.